Vaccines News
-
Australia further expands access to Japanese encephalitis vaccine
Vaccines | News | 0 Comment | 31 Jan, 2023
New South Wales (NSW) in Australia is further expanding free access to Japanese encephalitis (JE) vaccine to ensure resi...Read more
-
Korea's International Vaccine Institute opens Country Office in Austria
Vaccines | News | 0 Comment | 25 Jan, 2023
The International Vaccine Institute (IVI), based in Seoul (South Korea) has launched an IVI Country Office in&...Read more
-
Korea gives fast track approval to promising DNA vaccine for advanced cervical cancer
Vaccines | News | 0 Comment | 23 Jan, 2023
Genexine, a clinical-staged Korean biopharmaceutical company committed to the discovery and development of novel biologi...Read more
-
South Korea approves Novavax Nuvaxovid COVID-19 vaccine as adult booster
Vaccines | News | 0 Comment | 19 Jan, 2023
US-based Novavax, Inc. has announced that partner SK bioscience, based in South Korea, has received expanded manufacturi...Read more
-
Hayat-Vax to be first COVID-19 vaccine produced in Arab world
Vaccines | News | 0 Comment | 17 Jan, 2023
In a historic move in the global fight against the COVID-19 pandemic, the United Arab Emirates (UAE) has announced the c...Read more
-
New partnerships in Korea to transform mRNA technology into more vaccines
Vaccines | News | 0 Comment | 16 Jan, 2023
Gachon University, the Korea mRNA Vaccine Initiative (KmVAC), and the International Vaccine Institute (IVI) recently exc...Read more
-
Vaccines | News | 0 Comment | 12 Jan, 2023
South Korea headquatered SK bioscience, a global innovative vaccine and biotech company, has received a biologics licens...Read more
-
Demand booms for experimental mRNA in Australia
Vaccines | News | 0 Comment | 12 Jan, 2023
The University of Queensland (UQ) team has become the biggest supplier of experimental mRNA vaccines and therapies ...Read more
-
IVI, Batavia Biosciences sign MoU for vaccine research and development
Vaccines | News | 0 Comment | 10 Jan, 2023
The International Vaccine Institute (IVI), a South Korea-based international organisation devoted to vaccines for global...Read more
-
Nasal COVID-19 vaccine stored in NEST Disposable Intranasal Atomisation Device receives EUA in China
Vaccines | News | 0 Comment | 27 Dec, 2022
On December 2nd, a nasal spray COVID-19 vaccine, VectorFlu ONE, was approved for emergency use (EU) by the national auth...Read more
-
MSD signs pact with Indonesia's Bio Farma for HPV vaccine production
Vaccines | News | 0 Comment | 20 Dec, 2022
Bio Farma, Holding SOE Pharmacy – with its subsidiaries Kimia Farma and Indofarma, has signed a framework agreemen...Read more
-
China-based biotech startup's mRNA vaccine receives EUA in Laos
Vaccines | News | 0 Comment | 16 Dec, 2022
Chinese biotech startup Stemirna Therapeutics has received an Emergency Use Authorisation (EUA) from the FDA for ...Read more
-
Malaysia strives to develop children’s Hexavalent vaccine by 2023
Vaccines | News | 0 Comment | 14 Dec, 2022
Malaysia's Pharmaniaga LifeScience Sdn Bhd (PLS) and Pharmaniaga Berhad have signed a Research Collaboration Agreem...Read more
-
Moderna to expand Asia-Pacific presence with new Singapore subsidiary
Vaccines | News | 0 Comment | 12 Dec, 2022
Moderna, Inc., has announced its Singapore subsidiary with a new leadership announcement. Evelyn Pang has been ap...Read more
-
Takeda’s dengue tetravalent vaccine QDENGA receives approval in European Union
Vaccines | News | 0 Comment | 09 Dec, 2022
Japanese pharmaceutical firm Takeda has announced that the European Commission (EC) has granted marketing authorisation ...Read more
-
CEPI boosts 'Coronavirus X' vaccine search with expanded VBI Vaccines deal
Vaccines | News | 0 Comment | 08 Dec, 2022
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) is expanding its world-leading portfolio of potentia...Read more
-
Vaxxas raises A$34 M to clinically advance needle-free vaccines
Vaccines | News | 0 Comment | 06 Dec, 2022
Vaxxas has completed a financing round which raised $23 million (A$34 million) in new funds. This investment round was l...Read more
-
Australia takes aim at next pandemic threat with new vaccine platform
Vaccines | News | 0 Comment | 28 Nov, 2022
Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, is to put $5.7 million (AU$8.5 million) into the...Read more
